High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting
Differentiation of noninvasive from invasive papillary urothelial carcinoma can be challenging due to inability of proper orientation and thermal damage of transurethrally obtained material. The aim of this study was to analyze the presence and extent of peritumoral retractions in pT1 compared to pTa papillary urothelial carcinoma. Since peritumoral retractions may result from altered expression profiles of extracellular matrix proteins, we additionally analyzed the expression of matrix metalloproteinase 2 (MMP-2) and interleukin 8 (IL-8) in these tumors. The study comprised 50 noninvasive (pTa) and 50 invasive (pT1) cases of transurethrally obtained primary papillary urothelial carcinomas. The invasive nature of nests showing peritumoral retractions was confirmed immunohistochemically using antibody against collagen IV. Staining for MMP-2 and IL-8 was evaluated semiquantitatively using immunohistochemical staining index, calculated by multiplying the percentage of positive cells and staining intensity. Peritumoral retractions were found in 32% of pT1 carcinomas but in none of the pTa carcinomas. All tumors showing peritumoral retraction were high grade tumors. There was no statistically significant correlation between the expression of MMP-2 or IL-8 and the presence of peritumoral retractions or stage of the tumor (pTa vs. pT1). A statistically significant but weak correlation was found between MMP-2 and IL-8 expression (χ2-test, p=0,015). There was no statistically significant correlation between the presence of peritumoral retractions or MMP-2 expression and tumor recurrence and progression. Our study shows that, in doubtful cases, when differentiating between pTa and pT1 stages of papillary urothelial carcinoma, the presence of peritumoral retractions could favor the diagnosis of invasive neoplasm.
KeywordsUrinary bladder Papillary urothelial carcinoma Peritumoral retraction clefting Matrix metalloproteinase 2 Interleukin 8
This research was supported in part by the University of Zagreb funds for predoctoral fellows. We would like to thank Đurđica Poljan for the help in slide preparation, Milan Milošević for statistical analysis, and Davor Trnski, Davor Tomas and Sven Seiwerth for insightful comments.
Compliance with Ethical Standards
Conflict of Interest
The authors declare they have no conflict of interest.
- 2.Tumours of the Urinary System (2004) In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization classification of Tumours: pathology and genetics of Tumours of the urinary system and male genital organs, 3rd edn. IARC Press, Lyon, pp 90–123Google Scholar
- 3.Sobin LH, Gospodarowicz MK, Wittekind C (2010) International union against cancer. TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, ChichesterGoogle Scholar
- 4.Cheng L, Lopez-Beltran A, MacLennan GT, Montironi R, Bostwick DG (2014) Neoplasms of the urinary bladder. In: Bostwick DG, Cheng (eds) urologic surgical pathology, 3rd edn. Elsevier Saunders, Philadelphia, pp 243–268Google Scholar
- 11.Sangoi AR, Higgins JP, Rouse RV, Schneider AG, McKenney JK (2009) Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact. Mod Pathol 22:660–667CrossRefPubMedGoogle Scholar
- 15.Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78–85Google Scholar
- 16.Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376Google Scholar
- 19.Tumours of the Urinary System (2016) In: Moch H, Humphrey PA, Ulbright TM, Reuter VE (eds) World Health Organization classification of Tumours: pathology and genetics of Tumours of the urinary system and male genital organs, 4th edn. IARC Press, Lyon, pp 78–108Google Scholar
- 29.Acs G, Khakpour N, Kiluk J, Lee MC, Laronga C (2015) The presence of extensive retraction clefts in invasive breast carcinomas correlates with lymphatic invasion and nodal metastasis and predicts poor outcome: a prospective validation study of 2742 consecutive cases. Am J Surg Pathol 39:325–337CrossRefPubMedGoogle Scholar
- 32.Roy R, Louis G, Loughlin KR, Wiederschain D, Kilroy SM, Lamb CC, Zurakowski D, Moses MA (2008) Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. Clin Cancer Res 14:6610–6617CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Reis ST, Leite KR, Piovesan LF, Pontes-Junior J, Viana NI, Abe DK, Crippa A, Moura CM, Adonias SP, Srougi M, Dall’Oglio MF (2012) Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of bladder cancer. BMC Urol 12:18Google Scholar